Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient

The duration of viral shedding of SARS-CoV-2 is usually less than 10 days. We experienced a COVID-19 case with prolonged viral shedding for 2 months. His cell mediated immunity has been depressed (CD4+T cell <100/μl) due to advanced malignant lymphoma and chemotherapy which had been completed 4 m...

Full description

Saved in:
Bibliographic Details
Published inJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy Vol. 27; no. 2; pp. 387 - 389
Main Authors Nakajima, Yukiko, Ogai, Asuca, Furukawa, Karin, Arai, Ryosuke, Anan, Ryusuke, Nakano, Yasushi, Kurihara, Yuko, Shimizu, Hideaki, Misaki, Takako, Okabe, Nobuhiko
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.02.2021
Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd
Subjects
Online AccessGet full text
ISSN1341-321X
1437-7780
1437-7780
DOI10.1016/j.jiac.2020.12.001

Cover

More Information
Summary:The duration of viral shedding of SARS-CoV-2 is usually less than 10 days. We experienced a COVID-19 case with prolonged viral shedding for 2 months. His cell mediated immunity has been depressed (CD4+T cell <100/μl) due to advanced malignant lymphoma and chemotherapy which had been completed 4 months prior to the onset of symptoms of COVID-19. We administered several treatments against COVID-19, however the results of Polymerase Chain Reaction (PCR) from nasopharyngeal specimens remained positive to SARS-CoV-2 for 2 months. Moreover, virus isolation assays performed on Day 59 also remained positive. He was finally discharged on Day 69 with two consecutive negative PCR results for SARS-CoV-2. Immunocompromised status may prolong viral shedding and it is therefore important for the clinician to take into account this when assessing such patients.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1341-321X
1437-7780
1437-7780
DOI:10.1016/j.jiac.2020.12.001